Kelvin Siu Hoong Loke

Radioembolisation with Y90-resin microspheres followed by nivolumab for advanced hepatocellular carcinoma (CA 209-678): a single arm, single centre, phase 2 trial

David Tai, Kelvin Siu Hoong Loke, Apoorva Gogna et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 117 citations

Hepatology, Hepatocellular Carcinoma, Single Arm +10

Somatostatin receptor 2 expression in nasopharyngeal cancer is induced by Epstein Barr virus infection: impact on prognosis, imaging and therapy

Matt Lechner, Volker Hans Schartinger, Christopher D. Steele et al. · Nature Communications · 2021 · 61 citations · Full text

National Cancer Centre Singapore Consensus Guidelines for Hepatocellular Carcinoma

Pierce K. H. Chow, Su Pin Choo, David Chee Eng Ng et al. · Liver Cancer · 2016 · 52 citations · Full text

A phase II open-label, single-center, nonrandomized trial of Y90-radioembolization in combination with nivolumab in Asian patients with advanced hepatocellular carcinoma: CA 209-678.

Wai Meng David Tai, Kelvin Siu Hoong Loke, Apoorva Gogna et al. · Journal of Clinical Oncology · 2020 · 38 citations

Phase Ii Open-label, Y90-re Field, Pathology +16

Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical Trial

Stephen L. Chan, Chanisa Chotipanich, Su Pin Choo et al. · Liver Cancer · 2022 · 19 citations · Full text